A detailed history of Arlington Trust CO LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Arlington Trust CO LLC holds 290 shares of MRNA stock, worth $35,429. This represents 0.01% of its overall portfolio holdings.

Number of Shares
290
Previous 296 2.03%
Holding current value
$35,429
Previous $29,000 3.45%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$85.37 - $115.44 $512 - $692
-6 Reduced 2.03%
290 $30,000
Q4 2023

Jan 24, 2024

BUY
$69.51 - $104.43 $20,157 - $30,284
290 Added 4833.33%
296 $29,000
Q3 2023

Oct 24, 2023

BUY
$96.41 - $126.61 $578 - $759
6 New
6 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $47.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.